血清C肽与糖化血红蛋白联合检验诊断糖尿病价值分析

The Value of Serum C Peptide Combined With Glycosylated Hemoglobin in the Diagnosis of Diabetes Mellitus

目的观察血清C肽与糖化血红蛋白联合检验诊断糖尿病价值。方法选取24例2型糖尿病患者为观察组研究对象,纳入同期24名健康体检者为对照组研究对象,回顾性分析两组研究对象的临床资料,比较两组研究对象各项指标。结果观察组空腹血糖值为(8.62±1.30)mmol/L,高于对照组的(4.51±1.04)mmol/L;观察组患者血清C肽与糖化血红蛋白水平均高于对照组,差异均具有统计学意义(P<0.05)。结论临床对于糖尿病疑似患者进行诊断时,血清C肽与糖化血红蛋白联合检验的诊断价值较高。

Objective To observe the value of serum C peptide combined with glycosylated hemoglobin in the diagnosis of diabetes. Methods 24 patients with type 2 diabetes mellitus were selected as the observation group and 24 healthy subjects were selected as the control group. The clinical data of the two groups were analyzed retrospectively, and the indexes of the two groups were compared. Results The fasting blood glucose level in the observation group was（8.62±1.30） mmol/L, which was higher than that in the control group（4.51±1.04） mmol/L. The serum C peptide and glycosylated hemoglobin levels in the observation group were higher than those in the control group, and the differences were statistically significant（P 〈0.05）. Conclusion The clinical diagnosis value of serum C peptide and glycosylated hemoglobin combined test is higher in the diagnosis of suspected diabetic patients.